Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Omega-3 Fatty Acids (Zodin) on Post-Prandial Triglyceride Tolerance
2009-010207-83Phase 4Active
- Sponsor
- Saarland University
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of omega-3-acid ethyl ester in postprandial hypertriglyceridemia and coronary arteriosclerosis, sponsored by Saarland University. Primary endpoint: Post-prandial triglyceride kinetics after three weeks of Zodin. Started Mar 2009; status: active.
02
Drugs
omega-3-acid ethyl ester
03
Conditions
postprandial hypertriglyceridemiacoronary arteriosclerosis
Beyond the preview
Go deeper on 2009-010207-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010207-83.